DK2021794T3 - Anvendelse af protein S100A 12 som en markør for colorektal cancer - Google Patents

Anvendelse af protein S100A 12 som en markør for colorektal cancer

Info

Publication number
DK2021794T3
DK2021794T3 DK07725293.0T DK07725293T DK2021794T3 DK 2021794 T3 DK2021794 T3 DK 2021794T3 DK 07725293 T DK07725293 T DK 07725293T DK 2021794 T3 DK2021794 T3 DK 2021794T3
Authority
DK
Denmark
Prior art keywords
colorectal cancer
protein
marker
diagnosis
relates
Prior art date
Application number
DK07725293.0T
Other languages
Danish (da)
English (en)
Inventor
Andrea Geistanger
Michael Thierolf
Norbert Wild
Herbert Andres
Ursula Garczarek
Marie-Luise Hagmann
Johann Karl
Friedemann Krause
Michael Pfeffer
Wolfgang Rollinger
Michael Tacke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK2021794T3 publication Critical patent/DK2021794T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK07725293.0T 2006-05-19 2007-05-16 Anvendelse af protein S100A 12 som en markør for colorektal cancer DK2021794T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06010439 2006-05-19
PCT/EP2007/004378 WO2007134779A1 (en) 2006-05-19 2007-05-16 Use of protein s100a 12 as a marker for colorectal cancer

Publications (1)

Publication Number Publication Date
DK2021794T3 true DK2021794T3 (da) 2010-10-11

Family

ID=37087565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07725293.0T DK2021794T3 (da) 2006-05-19 2007-05-16 Anvendelse af protein S100A 12 som en markør for colorektal cancer

Country Status (15)

Country Link
US (3) US20090286328A1 (https=)
EP (1) EP2021794B8 (https=)
JP (1) JP4942813B2 (https=)
KR (1) KR101147586B1 (https=)
CN (1) CN101449163B (https=)
AT (1) ATE471512T1 (https=)
AU (1) AU2007251933B2 (https=)
BR (1) BRPI0711763A2 (https=)
CA (1) CA2651709A1 (https=)
DE (1) DE602007007209D1 (https=)
DK (1) DK2021794T3 (https=)
ES (1) ES2347485T3 (https=)
MX (1) MX2008014482A (https=)
PL (1) PL2021794T3 (https=)
WO (1) WO2007134779A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10957217B2 (en) 2006-08-25 2021-03-23 Ronald A. Weitzman Population-sample regression in the estimation of population proportions
US11151895B2 (en) * 2006-08-25 2021-10-19 Ronald Weitzman Population-sample regression in the estimation of population proportions
ATE521894T1 (de) * 2007-11-20 2011-09-15 Hoffmann La Roche Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
JP5461201B2 (ja) * 2008-01-31 2014-04-02 学校法人慶應義塾 抗がん剤感受性の判定方法
EP2816122A1 (en) 2008-02-15 2014-12-24 Mayo Foundation For Medical Education And Research Detecting neoplasm from a stool sample
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
CN103033623A (zh) * 2012-12-10 2013-04-10 天津市协和医药科技集团有限公司 人m2型丙酮酸激酶化学发光免疫分析试剂盒及制备方法
CA2902916C (en) 2013-03-14 2018-08-28 Mayo Foundation For Medical Education And Research Detecting neoplasm
CN104178562B (zh) * 2013-05-21 2018-11-09 生物梅里埃股份公司 一种大肠癌预后试剂盒
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
CN114574585A (zh) 2015-08-31 2022-06-03 梅约医药教育及研究基金会 检测胃肿瘤
CN107271681A (zh) * 2017-06-05 2017-10-20 中国人民解放军沈阳军区总医院 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用
AU2019252672B2 (en) 2018-04-12 2025-08-14 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
WO2021015619A1 (en) * 2019-07-23 2021-01-28 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Progression markers for colorectal adenomas
AU2020365127B2 (en) * 2019-10-18 2026-04-09 Exact Sciences Corporation Multiple analyte fecal antigen testing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137064A (ja) * 1984-12-07 1986-06-24 Fujirebio Inc 大腸癌の予備スクリ−ニング方法
DE3838900A1 (de) * 1988-11-17 1990-05-23 Scheefers Borchel Ursula Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung
JPH02193071A (ja) * 1989-01-20 1990-07-30 Green Cross Corp:The ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法
JPH08238090A (ja) * 1995-03-06 1996-09-17 Jiro Hitomi 新規カルシウム結合タンパク
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Ｔｉｍｐ１を用いた検出方法
EP2295976A1 (en) * 2003-03-08 2011-03-16 Auvation Ltd Markers for colorectal cancer
WO2005054508A2 (en) * 2003-12-01 2005-06-16 Ipsogen Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
ATE494391T1 (de) * 2004-07-23 2011-01-15 Aspenbio Pharma Inc Verfahren und vorrichtungen zur diagnose von appendizitis

Also Published As

Publication number Publication date
JP2009537798A (ja) 2009-10-29
AU2007251933A1 (en) 2007-11-29
MX2008014482A (es) 2008-11-27
WO2007134779A1 (en) 2007-11-29
CN101449163B (zh) 2014-06-25
HK1133295A1 (en) 2010-03-19
BRPI0711763A2 (pt) 2011-12-06
EP2021794B1 (en) 2010-06-16
US20150192587A1 (en) 2015-07-09
EP2021794B8 (en) 2010-08-18
US20170115294A1 (en) 2017-04-27
DE602007007209D1 (de) 2010-07-29
ES2347485T3 (es) 2010-10-29
CN101449163A (zh) 2009-06-03
US20090286328A1 (en) 2009-11-19
KR20090007454A (ko) 2009-01-16
EP2021794A1 (en) 2009-02-11
AU2007251933B2 (en) 2011-05-12
JP4942813B2 (ja) 2012-05-30
PL2021794T3 (pl) 2010-12-31
KR101147586B1 (ko) 2012-08-23
CA2651709A1 (en) 2007-11-29
ATE471512T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
ATE554389T1 (de) Apex als marker für lungenkrebs
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP2262911A4 (en) COMPOSITIONS, PROCESSES AND KITS WITH SYNTHETIC PROBES FOR DETECTING THE PRESENCE OF A TARGET NUCLEIC ACID
EP2321430B8 (en) Method of evaluating oral cancer risk in human
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
MX2010005893A (es) Marcadores de expresion genica para enfermedad inflamatoria de intestino.
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2010136163A8 (en) Secernin-1 as a marker for cancer
EP2212700B8 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
JP2009537798A5 (https=)
DK2211180T3 (da) Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer
EP2019836A4 (en) PROCESSES, COMPOSITIONS AND KITS FOR DETECTING PROTEIN AGGREGATES
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
EP2238431A4 (en) DEVELOPMENT AND USE OF CYSTEIN-MARKED FLUORESCENT PROBLEMS FROM UNBUNDLED ANALYTES
EP2075341A4 (en) METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
ATE476655T1 (de) Doxorubicin-immuntest
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
CL2007003659A1 (es) Kit de deteccion de microorganismos patogenos mediante pruebas de aliento.
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
EA200801533A1 (ru) Производные антрахинона в качестве маркирующих веществ для жидкостей
DK2274623T3 (da) Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer